Search - tctmd.com

Displaying 161 - 180 of 181

Sort: Relevancy | Date

Presentation TCT 2013

Watchman

Presenter: Saibal Kar

October 27, 2013

Presentation TCT 2013

Deep Dive of the Watchman Data: PROTECT AF, CAP, and PREVAIL Efficacy

Presenter: David Holmes Jr

October 27, 2013

Presentation TCT 2013

Deep Dive of the Watchman Data: PROTECT AF, CAP AND PREVAIL Safety Issues

Presenter: Saibal Kar

October 27, 2013

Presentation TVT 2013

The Watchman Device: Form vs. Function

Presenter: Maurice Buchbinder

June 15, 2013

Presentation TVT 2013

How to Avoid Complications with the Watchman Device

Presenter: Ted Feldman

June 15, 2013

Presentation TVT 2013

Complex LAA Anatomy (Watchman Closure): Chicken Wing Morphology

Presenter: Steven Yakubov

June 15, 2013

Presentation TVT 2013

Transcatheter Closure of Incomplete Left Atrial Appendage Occlsuion (Previous Watchman LAA Occluder) - Implantation of a 2nd Generation ACP (Amulet) Device

Presenter: Simon Cheung Chi Lam

June 14, 2013

Presentation

LAA Closure with the Watchman Device in Patients with a Contraindication for Oral Anticoagulation

Presenter: Vivek Y. Reddy

April 09, 2013

Presentation TCT 2012

Transcatheter LAA Occlusion: The Watchman Experience as Proof of Principle

Presenter: David Muller

October 24, 2012

Presentation TCT 2012

WATCHMAN Tips and Tricks

Presenter: Peter Sick

October 23, 2012

Presentation TCT 2012

The New Fourth-Generation WATCHMAN (BSC-Atritech): Device Design and Results of the EVOLVE Trial

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

TCT-84. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients 75 Years or Greater; A Sub-Analysis of the PROTECT AF Study

Presenter: Saibal Kar

October 23, 2012

Presentation TCT 2012

TCT-83. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients with Contraindication to Oral Anticoagulation: the “Aspirin Plavix Registry” (ASAP)

Presenter: Horst Sievert

October 23, 2012

Presentation TCT 2012

Case Presentation: A Complicated WATCHMAN Case

Presenter: Horst Sievert

October 23, 2012

Presentation TVT 2012

The Watchman Clinical Studies Program (Warfarin Eligible): Perspectives, New Insights, and Future Directions

Presenter: Saibal Kar

June 05, 2012

Presentation TVT 2012

Taped Case Study: The Watchman Procedure(2)

Presenter: Saibal Kar

June 05, 2012

Presentation TVT 2012

ASAP Results: The Watchman in Warfarin Ineligible Patients

Presenter: Shephal Doshi

June 05, 2012

Presentation

Watchman LAA Closure in A-fib Patients with Contraindication to Oral Anticoagulation

Presenter: Vivek Y. Reddy

May 30, 2012

Presentation

The Clinical Impact of Incomplete LAA Closure With the Watchman Device in Patients With A-fib

Presenter: J. Viles-Gonzalez

February 26, 2012

Presentation

Impacto Clínico del Cierre Incompleto del AAI con el Dispositivo Watchman en Pacientes con Fibrilación Auricular

Presenter: J. Viles-Gonzalez

February 26, 2012

Advertisement

Watchman

Deep Dive of the Watchman Data: PROTECT AF, CAP, and PREVAIL Efficacy

Deep Dive of the Watchman Data: PROTECT AF, CAP AND PREVAIL Safety Issues

The Watchman Device: Form vs. Function

How to Avoid Complications with the Watchman Device

Complex LAA Anatomy (Watchman Closure): Chicken Wing Morphology

Transcatheter Closure of Incomplete Left Atrial Appendage Occlsuion (Previous Watchman LAA Occluder) - Implantation of a 2nd Generation ACP (Amulet) Device

LAA Closure with the Watchman Device in Patients with a Contraindication for Oral Anticoagulation

Transcatheter LAA Occlusion: The Watchman Experience as Proof of Principle

WATCHMAN Tips and Tricks

The New Fourth-Generation WATCHMAN (BSC-Atritech): Device Design and Results of the EVOLVE Trial

TCT-84. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients 75 Years or Greater; A Sub-Analysis of the PROTECT AF Study

TCT-83. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients with Contraindication to Oral Anticoagulation: the “Aspirin Plavix Registry” (ASAP)

Case Presentation: A Complicated WATCHMAN Case

The Watchman Clinical Studies Program (Warfarin Eligible): Perspectives, New Insights, and Future Directions

Taped Case Study: The Watchman Procedure(2)

ASAP Results: The Watchman in Warfarin Ineligible Patients

Watchman LAA Closure in A-fib Patients with Contraindication to Oral Anticoagulation

The Clinical Impact of Incomplete LAA Closure With the Watchman Device in Patients With A-fib

Impacto Clínico del Cierre Incompleto del AAI con el Dispositivo Watchman en Pacientes con Fibrilación Auricular

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content